MedPath
NMPA Approval

Cross-linked Sodium Hyaluronate Injection

国药准字HJ20160464

July 29, 2021

H20160464

Drug Information

交联玻璃酸钠注射液

欣维可

注射剂

2ml:玻璃酸钠16mg

化学药品

July 29, 2021

July 28, 2026

Company Information

Applicant Company

50 Binney Street Cambridge, MA 02142,USA

Manufacturing Company

1125 Pleasant View Terrace, Ridgefield, New Jersey 07657, USA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

交联玻璃酸钠注射液 - NMPA 批准文号 | MedPath